Antigen presenting mesenchymal stem cells
View Patent ↗Disclosed is a mesenchymal stem cell and/or cell of the adipocyte lineage that (i) has been modified to have at least one exogenous antigen bound to at least one primary surface molecule of said cell such that said at least one antigen can initiate an immune response and (ii) also expresses at least one co-stimulatory molecule. The antigen is preferably a protein, polypeptide, lipid or glycolipid. The primary surface molecule is MHC I, MHC II or CD1. Also disclosed is a method for stimulating presentation of at least one exogenous antigen fragment on a mesenchymal stem cell primary surface molecule by contacting a mesenchymal stem cell that is capable of expressing at least one co-stimulatory molecule with (i) an exogenous antigen or (ii) genetic material that codes for the exogenous antigen which the mesenchymal stem cell processes into at least one antigen fragment. The method can further include contacting the mesenchymal stem cell with interferon-γ. Also disclosed are a method for determining the state of activation of a T lymphocyte population and a method for the treatment or prevention of a disease in an animal.
1. A composition comprising a mesenchymal stem cell that expresses at least one co-stimulatory molecule, wherein said mesenchymal stem cell has been treated with interferon-γ, and has been modified to have at least one exogenous antigen fragment bound to MHCII such that said at least one antigen is presented to initiate an immune response.
2. The composition of claim 1 wherein said mesenchymal stem cell further includes exogenous genetic material that encodes interferon-γ.
3. The composition of claim 1 wherein the co-stimulatory molecule is selected from the group consisting of B7-1 and B7-2.
4. The composition of claim 1 wherein the exogenous antigen is selected from the group consisting of a protein, a polypeptide, a glycolipid, and a lipid.
5. The composition of claim 1 wherein the mesenchymal stem cell was modified by contact with the exogenous antigen fragment or an antigen including said fragment.
6. The composition of claim 1 wherein the mesenchymal stem cell contains exogenous genetic material that encodes the exogenous antigen fragment or an antigen including said fragment.
7. The composition of claim 6 wherein said exogenous genetic material is contained in an expression vector.
8. The composition of claim 1 wherein the mesenchymal stem cell includes exogenous genetic material that encodes said at least one co-stimulatory molecule.
9. The composition of claim 8 wherein said exogenous genetic material encoding said at least one co-stimulatory molecule is contained in an expression vector.
10. A composition comprising a cell of the adipocyte lineage that expresses at least one co-stimulatory molecule, wherein said cell has been treated with interferon-γ, and has been modified to have at least one exogenous antigen fragment bound to MHC II of said cell such that said at least one antigen is presented to initiate an immune response.
11. The composition of claim 10 wherein said cell further includes exogenous genetic material that encodes interferon-γ.
12. The composition of claim 10 wherein the co-stimulatory molecule is selected from the group consisting of B7-1 and B7-2.
13. The composition of claim 10 wherein the exogenous antigen is selected from the group consisting of a protein, a polypeptide, a glycolipid, and a lipid.
14. The composition of claim 10 wherein the cell was modified by contact with the exogenous antigen fragment or an antigen including said fragment.
15. The composition of claim 10 wherein the cell contains exogenous genetic material that encodes the exogenous antigen fragment or an antigen including said fragment.
16. The composition of claim 15 wherein said exogenous genetic material is contained in an expression vector.
17. The composition of claim 10 wherein the cell includes exogenous genetic material that encodes at least one co-stimulatory molecule.
18. The composition of claim 17 wherein said exogenous genetic material encoding said at least one co-stimulatory molecule is contained in an expression vector.